Notizie AIOM – anno XVI n. 681

26 Giugno 2018

ASCO Guideline for Geriatric Oncology: Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy

June 15, 2018 - As reported in the Journal of Clinical Oncology by Supriya G. Mohile, MD, of the University of Rochester Medical Center, and colleagues, ASCO has produced a guideline on the practical assessment and management of vulnerabilities in geriatric patients receiving ...
Leggi tutto

26 Giugno 2018

Modernising the orphan designation process

June 19, 2018 - The European Medicines Agency (EMA) has launched a new secure online portal for orphan designationExternal link icon applications. The portal, named 'Iris', provides a single space where applicants can submit and manage the information and documents related ...
Leggi tutto

26 Giugno 2018

Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study

Collecting duct carcinoma (CDC) is a rare type of renal cancer with a poor prognosis. As there are no standard guidelines for the management of metastatic CDC (mCDC), we evaluated the efficacy and safety of combined therapies of sorafenib, gemcitabine, plus cisplatin in ...
Leggi tutto

26 Giugno 2018

22 giugno 2018 – Carenza fludrocortisone acetato – modalità di richiesta d’importazione dall’estero

26 Giugno 2018

AMA Plans Advocacy Outreach to Expand Colorectal Screening

June 22, 2018 - Building on the efficacy of colorectal cancer screening, the American Medical Association (AMA) endorsed a plan at its Annual Meeting to work with physicians and payers to make the screening more available and affordable. Challenges with insurance coverage ...
Leggi tutto

26 Giugno 2018

Statement From FDA Commissioner on Agency Efforts to Advance the Patient Voice in Medical Product Development and Regulatory Decision-Making

June 22, 2018 - U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, recently issued the following statement: Over the past decade, advances in our understanding of the basic biology of serious and life-threatening diseases has led to the development ...
Leggi tutto

26 Giugno 2018

FDA Grants Priority Review to Expanded Use of Gardasil 9 in Women and Men Aged 27 to 45 for the Prevention of Certain HPV-Related Cancers and Diseases

June 22, 2018 - On June 13, the U.S. Food and Drug Administration (FDA) accepted for review a new supplemental biologics license application (sBLA) for recombinant human papillomavirus (HPV) 9-valent vaccine. The application is seeking approval for an expanded age indication—ie, ...
Leggi tutto

26 Giugno 2018

Reinforced EU/US collaboration on medicines

June 22, 2018 - Senior officials from the European CommissionExternal link icon (EC), the European Medicines Agency (EMA) and the United States Food and Drug AdministrationExternal link icon (FDA) held their 2018 bilateral meeting in Brussels, Belgium, on 18 and 19 June. ...
Leggi tutto

22 Giugno 2018

AMA Releases New Physician Guide on Caring for the Caregiver

June 14, 2018 - Every day in their treatment rooms, physicians encounter individuals who are making profound sacrifices to help a loved one who is seriously ill, often at the expense of their own well-being. To help physicians understand the day-to-day challenges and risk ...
Leggi tutto

22 Giugno 2018

ASCO/CAP Clinical Practice Guideline Focused Update on HER2 Testing in Breast Cancer

June 21, 2018 - As reported in the Journal of Clinical Oncology by Antonio C. Wolff, MD, of Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, and colleagues, ASCO and the College of American Pathologists (CAP) have issued a clinical practice guideline focused update ...
Leggi tutto

LAVORIAMO CON

News

ICTUS, SCARSA QUALITÀ DELLA VITA NEL POST RIABILITAZIONE PER 1 PAZIENTE SU 4

SCOPERTE 74 REGIONI DNA LEGATE A METABOLISMO E CHILI DI TROPPO

BRISTOL MYERS SQUIBB OTTIENE L’APPROVAZIONE DELLA COMMISSIONE EUROPEA PER NIVOLUMAB NEL TRATTAMENTO ADIUVANTE DI PAZIENTI CON TUMORE ESOFAGEO O DELLA GIUNZIONE GASTRO-ESOFAGEA CON MALATTIA PATOLOGICA RESIDUA DOPO CHEMIO-RADIOTERAPIA

ACTO LOMBARDIA RINNOVA GLI APPUNTAMENTI CON “LA CASA DELLE DONNE”

ACTO PUGLIA PORTA “MOVIMENTO E SALUTE” IN REGIONE

CELGENE, ORA PARTE DI BRISTOL-MYERS SQUIBB, ANNUNCIA I RISULTATI PRELIMINARI DELLO STUDIO A LUNGO TERMINE CHE RAFFORZANO IL PROFILO DI EFFICACIA E SICUREZZA DI OZANIMOD NEI PAZIENTI CON FORME RECIDIVANTI DI SCLEROSI MULTIPLA

POLIAMBULANZA, 20 POSTI LETTO PER I PAZIENTI SUB ACUTI PRESSO LA RSA KORIAN “COSI’ PROVIAMO A SUPERARE I LIMITI IMPOSTI DALLA PANDEMIA”

Notizie AIOM – anno XVI n. 681

ASCO Guideline for Geriatric Oncology: Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy

Modernising the orphan designation process

Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study

22 giugno 2018 – Carenza fludrocortisone acetato – modalità di richiesta d’importazione dall’estero

AMA Plans Advocacy Outreach to Expand Colorectal Screening

Statement From FDA Commissioner on Agency Efforts to Advance the Patient Voice in Medical Product Development and Regulatory Decision-Making

FDA Grants Priority Review to Expanded Use of Gardasil 9 in Women and Men Aged 27 to 45 for the Prevention of Certain HPV-Related Cancers and Diseases

Reinforced EU/US collaboration on medicines

AMA Releases New Physician Guide on Caring for the Caregiver

ASCO/CAP Clinical Practice Guideline Focused Update on HER2 Testing in Breast Cancer